TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
EDIT

Editas Medicine Inc

Healthcare · Biotechnology

2.70$ -0.7% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Editas Medicine Inc (EDIT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 187 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet EDIT
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
12 149 229 373 420 509 573 677 514 499 342 187
11 145 187 332 375 464 419 507 357 341 289 164
11 143 185 147 135 238 140 204 142 124 132 147
11 143 185 329 369 457 402 500 344 323 270 147
1.0 1.0 0.1 0.7 0.0 0.4 6.0 0.3 5.1 10 16 15
0.8 1.7 1.9 2.9 -110 -120 -93
1.1 2.1 40 39 40 40 14 17 16
0.0 0.0
0.0 0.0
27 232 95 165 184 246 179 124 154 150 207 159
6.2 6.9 33 37 36 60 58 47 60 63 77 46
0.1 10 10 7.5 13 5.8 6.8 10 11 24 15 11
2.6 1.4 4.6 4.0 5.3 5.8 6.4 5.1 9.5 8.3 5.5 2.6
0.3 35 35 33
-15 -83 135 208 236 262 394 554 361 349 134 27
-15 -88 -186 -306 -416 -549 -665 -858 -1,078 -1,231 -1,468 -1,629
2.6 36 32 40 47 50 59 68 69 76 82 89

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?